TY - JOUR
T1 - PET/Computed Tomography in Breast Cancer
T2 - Can It Aid in Developing a Personalized Treatment Design?
AU - Suresh Malapure, Sumeet
AU - Das, Kalpa Jyoti
AU - Kumar, Rakesh
N1 - Publisher Copyright:
© 2016 Elsevier Inc.
PY - 2016/7/1
Y1 - 2016/7/1
N2 - PET with fluorodeoxyglucose (FDG-PET)/computed tomography (CT) imaging has significantly improved the management of breast cancer. FDG, however, is not tumor-specific and various image interpretation pitfalls may occur due to false-positive and false-negative causes of FDG uptake. PET/CT imaging with more specific radiopharmaceuticals may provide useful information about the pathophysiology in such cases. In the present article, we reviewed the use of whole-body FDG-PET/CT and 18F-16α-17β-Fluoroestradiol PET/CT imaging to determine if these can be used to develop personalized treatment design for the better management of breast cancer.
AB - PET with fluorodeoxyglucose (FDG-PET)/computed tomography (CT) imaging has significantly improved the management of breast cancer. FDG, however, is not tumor-specific and various image interpretation pitfalls may occur due to false-positive and false-negative causes of FDG uptake. PET/CT imaging with more specific radiopharmaceuticals may provide useful information about the pathophysiology in such cases. In the present article, we reviewed the use of whole-body FDG-PET/CT and 18F-16α-17β-Fluoroestradiol PET/CT imaging to determine if these can be used to develop personalized treatment design for the better management of breast cancer.
UR - http://www.scopus.com/inward/record.url?scp=84963954460&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84963954460&partnerID=8YFLogxK
U2 - 10.1016/j.cpet.2016.02.006
DO - 10.1016/j.cpet.2016.02.006
M3 - Review article
C2 - 27321033
AN - SCOPUS:84963954460
SN - 1556-8598
VL - 11
SP - 297
EP - 303
JO - PET Clinics
JF - PET Clinics
IS - 3
ER -
